Business Context and Reporting Period
Company: Midland States Bancorp, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 24, 2025
Reporting Period: The filing addresses errors in financial statements for the years ended December 31, 2022 and 2023, and interim periods through September 30, 2024 (collectively, the "Affected Periods"). It also pertains to the year ended December 31, 2024, which is currently being restated.
Key Financial Metrics and Status
The filing does not provide specific numerical values for revenue, profit, cash flow, or margins for the current period due to the ongoing restatement process. Key financial implications include:
- Accounting Error: Errors were identified in the accounting for loans originated under third-party programs dating back to 2012. Payments previously recorded on a net basis as interest income must be reclassified to a gross basis, with credit enhancement payments recorded separately as credit indemnification derivatives.
- Impact on Net Income: Net income for the Affected Periods and the year ended December 31, 2024, will be affected by the timing of credit loss provisions and the valuation of credit indemnification derivatives.
- Capital Ratios: The changes are not expected to materially affect tangible equity or regulatory capital ratios as of December 31, 2024.
- Portfolio Sales: The company sold participation interests in consumer loans representing approximately $330 million (89% of the GreenSky portfolio) in April 2025. The LendingPoint portfolio was sold in December 2024.
Material Changes Versus Prior Periods
The primary material change is the non-reliance on previously issued audited and unaudited financial statements for the Affected Periods. The Audit Committee concluded these statements should no longer be relied upon due to accounting errors regarding loan origination programs. Consequently, the company plans to restate financial statements for 2022, 2023, and interim periods in its upcoming 2024 Annual Report (Form 10-K).
Guidance, Outlook, Risks, and Unusual Items
- Restatement Plan: The company will restate financial statements in the 2024 Annual Report, including an adjustment to beginning shareholders' equity as of January 1, 2022.
- Goodwill Impairment: The company is evaluating potential goodwill impairment. If an impairment exists, it would not affect tangible equity or regulatory capital ratios.
- Internal Controls: Management identified material weaknesses in internal control over financial reporting related to the accounting errors. A remediation plan will be detailed in the 2024 Annual Report.
- Upcoming Earnings: An abbreviated earnings release for the quarter ended March 31, 2025, is expected on or about April 30, 2025.
- Shareholder Meeting: The 2025 Annual Meeting of Shareholders will be scheduled after the filing of the 2024 Annual Report.
Investor Verification Checklist
- Verify the magnitude of the restatement adjustments to net income and equity once the 2024 Annual Report is filed.
- Confirm the results of the ongoing goodwill impairment evaluation.
- Review the specific remediation plan for the identified material weaknesses in internal controls.
- Monitor the timing of the 2024 Annual Report filing, as delays have already occurred.
- Assess the impact of the $330 million GreenSky portfolio sale on future earnings and liquidity.